IP Library Granted Patent US 11,154,398
Granted Patent B2
US 11,154,398 · App. 17/238,055 · Granted Oct 26, 2021

Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient

Inventors: Helmut Straubinger (Ascheim, DE); Johannes Jung (Pforzheim-Huchenfeld, DE); Michael J. Girard (Lino Lakes, MN); Arnulf Mayer (Markt Schwaben, DE)
Assignee: JenaValve Technology. Inc.
A61F2/2418A61F2/07A61F2/2409A61F2/2412A61F2220/0058A61F2220/0075A61F2230/0023A61F2230/0054
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,154,398
App. No.
17/238,055
Granted
Oct 26, 2021
Kind
B2
Abstract

A method of placing an implant including a stent at a native heart valve site includes orienting an expandable body of the stent such that a first open end of the stent is upstream a second open end of the stent relative to a direction of blood flow through a native heart valve. The native heart valve includes native leaflets and an annulus. The method also includes radially expanding a plurality of positioning arches positioned around an outer perimeter of the expandable body. The method additionally includes inserting the plurality of positioning arches respectively within a plurality of pockets defined by leaflets of the native heart valve and a heart structure from which the native leaflets extend. The method further includes radially expanding the first open end of the stent into a position upstream of the annulus and out of contact with nerve bundles.

Claims (24)

1. A stent-valve prosthesis for implantation at a patient's native heart valve, the stent-valve prosthesis comprising:

a stent comprising a first end, a second end, a plurality of first arches, and a plurality of second arches, each of the plurality of first arches having a first apex oriented towards the first end and each of the plurality of second arches having a second apex oriented towards the second end, the stent comprising a plurality of rows of cells comprising an end row of cells at the second end of the stent having more cells around a circumference of the stent than any other row; and

a plurality of prosthetic leaflets coupled to the stent and configured to, when opened, permit blood flow therethrough when the stent-valve prosthesis is implanted at the native heart valve.

2. The stent-valve prosthesis of claim 1 , wherein a plurality of first fastening means are disposed on the plurality of first arches.

3. The stent-valve prosthesis of claim 2 , wherein the plurality of prosthetic leaflets are coupled to the plurality of first fastening means.

4. The stent-valve prosthesis of claim 1 , wherein a plurality of second fastening means are disposed on the end row of cells.

5. The stent-valve prosthesis of claim 4 , wherein the plurality of prosthesis leaflets are coupled to the plurality of second fastening means.

6. The stent-valve prosthesis of claim 1 , further comprising at least one radio opaque marker disposed on at least one of the plurality of second arches.

7. The stent-valve prosthesis of claim 1 , wherein the second end of the stent flares radially outward with respect to the first end of the stent.

8. The stent-valve prosthesis of claim 1 , wherein the plurality of first arches is coupled to the plurality of second arches at the first apex of each of the plurality of first arches.

9. The stent-valve prosthesis of claim 1 , wherein the stent-valve prosthesis is configured to transition between a collapsed state and an expanded state.

10. The stent-valve prosthesis of claim 9 , wherein the end row of cells is configured to press against the native heart valve of the patient in the expanded state when the stent-valve prosthesis is implanted at the native heart valve.

11. The stent-valve prosthesis of claim 10 , wherein the stent-valve prosthesis is configured to seal against a vascular wall of the patient in the expanded state when the stent-valve prosthesis is implanted at the native heart valve.

12. The stent-valve prosthesis of claim 1 , wherein the plurality of second arches consists of three second arches.

13. The stent-valve prosthesis of claim 1 , wherein the end row of cells is coupled to the plurality of first arches.

14. The stent-valve prosthesis of claim 1 , wherein at least a portion of the plurality of rows of cells is coupled to the plurality of first arches.

15. The stent-valve prosthesis of claim 1 , wherein the stent further comprises a plurality of third arches having a third apex oriented towards the first end.

16. The stent-valve prosthesis of claim 15 , wherein the plurality of third arches are coupled to the plurality of second arches.

17. The stent-valve prosthesis of claim 1 , wherein the plurality of first arches and the plurality of second arches include a substantially U-shaped or V-shaped structure.

18. The stent-valve prosthesis of claim 1 , wherein the stent further comprises retaining means disposed at the first end, the retaining means configured to be releasably coupled to a catheter system.

19. The stent-valve prosthesis of claim 18 , wherein the retaining means extend from the plurality of the first arches.

20. A stent-valve prosthesis for implantation at a patient's native heart valve, the stent-valve prosthesis comprising:

a stent comprising a first end, a second end, a plurality of first arches, and a plurality of second arches, each of the plurality of first arches having a first apex oriented towards the first end and each of the plurality of second arches having a second apex oriented towards the second end, the stent further comprising a first row of cells and a second row of cells, the second row of cells disposed at the second end of the stent and having more cells around a circumference of the stent than the first row of cells; and

a plurality of prosthetic leaflets coupled to the stent and configured to, when opened, permit blood flow therethrough when the stent-valve prosthesis is implanted at the native heart valve.

Assignments (5)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 28, 2022
From: JENAVALVE TECHNOLOGY, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 058894/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2021
From: STRAUBINGER, HELMUT; JUNG, JOHANNES; GIRARD, MICHAEL; MAYER, ARNULF
To: JENAVALVE TECHNOLOGY, INC.
Reel/Frame 056043/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2021
From: JENAVALVE TECHNOLOGY, INC.
To: JENAVALVE TECHNOLOGY GMBH
Reel/Frame 056044/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2021
From: JENAVALVE TECHNOLOGY GMBH
To: JVT RESEARCH & DEVELOPMENT CORPORATION
Reel/Frame 056044/0120 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2021
From: JVT RESEARCH & DEVELOPMENT CORPORATION
To: JENAVALVE TECHNOLOGY, INC.
Reel/Frame 056044/0175 →
Cited By (19)
US 12,232,957 US 12,232,991 US 12,318,281 US 12,343,255 US 12,414,854 US 12,433,745 US 12,453,630 US 12,544,226 US 12,569,336 US 12,582,520 US 12,588,988 US 12,588,989 US 12,588,998 US 12,594,164 US 12,599,481 US 12,616,593 US 12,636,146 US 12,636,148 US 12,642,650